Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Steve Davis, MD, is Department Chair in the Department of Pediatric Critical Care, as well as Vice Chairman of Physician Staff Development in the Pediatric Division Office and has appointments in Medical Operations as director of ICU operations and in Regional Operations as Executive Director of Critical Care for CCHS. His special interests include pediatric critical care medicine and operational excellence.
He holds a number of certifications, including being Diplomate of the National Board of Medical Examiners, Diplomate of the American Board of Pediatrics, Board Certified in Pediatric Critical Care, Fellow of the American Academy of Pediatrics, and Fellow of the Critical Care Medicine Society.
He earned his medical degree from the University of Vermont College of Medicine in Burlington, VT. He was a Pediatric Resident at Children’s Hospital of Pittsburgh in Pittsburgh, Pa., and he was a Pediatric Critical Care Fellow a Johns Hopkins Hospital in Baltimore, Md.
Dr. Davis is a member of several professional organizations, including the American Academy of Pediatrics, Society of Critical Care Medicine, and the American College of Chest Physicians. He was named one of the Best Doctors in America from 2003-2011. He received the Chairman’s Award for Pediatric Research in 2002 and the Chairman's Award for Mentoring in 2005.
He has published a number of articles, book chapters and abstracts on topics such as pediatric cardiac surgery, and pediatric critical care medicine.
business intelligence and operations, cardiac critical care, pediatric critical care medicine
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/6/2014, Dr. Davis has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.